Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Short & Caught: Who was once short, but now they’re long on City Chic?
Health & Biotech
Clinical Trials 101: The critical review process and getting drugs to market
News
ASX Large Caps: Shareholders caught with pants down in brutal selloff on Wednesday
News
Short & Caught: Popular lithium plays among most shorted ASX stocks
Experts
ScoPo’s Powerplays: ASX health stocks finish reporting season in pretty strong shape
News
Trading Places: BGH ups Virtus stake to above 50pc as battle for fertility company escalates
News
Short & Caught: Flight Centre hits turbulence as ASX’s most shorted stock
News
ASX Small Cap Lunch Wrap: Who’s deconstructing their tendies today?
Health & Biotech
ASX Health Stocks: Clinuvel reveals study results, and Cann’s Mildura cannabis facility is a go
Health & Biotech
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks
Experts
ScoPo’s Powerplays: Who’s staying afloat in the inflation storm?
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Mesoblast and the ASX’s other big biotechs have intrigued investors this year; here’s what’s in store next
Health & Biotech
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
Health & Biotech
